Michael Hay, MD
Urology · Orangeburg, SCNPI 1336145408
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 90.9% of the total across 65 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 20 manufacturers reported payments, led by Astellas Pharma US Inc at 31.3% of the total. Reporting peaked in 2019 at $524 and has fallen 96.9% since, to $16 in 2024. That places this record below the midpoint for urology clinicians in SC, where the typical reported total is $3,399.
Across 65 payments — averaging $19.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astellas Pharma US Inc$393
- Johnson & Johnson$118
- Medtronic$100
- AbbVie$96
- Pfizer$94
- Rochester Medical Corporation$66
- plus $390 from 14 others
What the payments were for
- Food & beverage$1,14291%
- Education$1149%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astellas Pharma US Inc | 17 | $393 |
| Johnson & Johnson | 7 | $118 |
| Medtronic(2 entities) | 6 | $100 |
| AbbVie(2 entities) | 6 | $96 |
| Pfizer | 6 | $94 |
| Rochester Medical Corporation | 4 | $66 |
| Covidien LP | 1 | $66 |
| Coloplast | 2 | $62 |
| Ferring Pharmaceuticals Inc. | 3 | $53 |
| Myriad Genetic Laboratories, Inc. | 2 | $35 |
| Boston Scientific | 2 | $24 |
| Dendreon Pharmaceuticals LLC | 1 | $23 |
| Myovant Sciences Inc. | 1 | $21 |
| Antares Pharma, Inc. | 1 | $17 |
| Teleflex LLC | 1 | $17 |
| Amgen | 1 | $17 |
| Laborie Medical Technologies Corp. | 1 | $16 |
| Avadel Specialty Pharmaceuticals, LLC | 1 | $14 |
| AstraZeneca | 1 | $13 |
| 180 Medical, Inc. | 1 | $12 |
How this compares
$1,256 in reported general payments places this provider in the 35th percentile of 196 urology providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other urology in Orangeburg
- Neal ShoreMyrtle Beach$3.2M
- Manish PatelElgin$213K
- Sandip PrasadCharleston$177K
- Benjamin DropkinGreenville$65K
- Ian MarshallCharleston$60K
- Elizabeth BozemanFlorence$57K
- Thomas KeaneCharleston$52K
- Abhishek SrivastavaMyrtle Beach$41K
- William BogacheMyrtle Beach$41K
- Christopher BallantyneGreenville$37K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.